CD274 and nasopharyngeal carcinoma: We directly applied our assay to a clinical analysis of circulating TEVs from 50 μL of serum, revealing potential applications of nucleolin+ TEVs for nasopharyngeal carcinoma cancer (NPC) diagnosis and PD-L1+ TEVs for therapeutic monitoring.